Meningitec Meningitec Teresa Davis 2011
Jan 02, 2016
MeningitecMeningitec
Teresa Davis 2011
MeningitecMeningitec
Meningococcal Serogroup C Conjugate Meningococcal Serogroup C Conjugate VaccineVaccine
1 of 3 vaccines to protect against 1 of 3 vaccines to protect against Neisseria meningitidis group CNeisseria meningitidis group C
Does not proctect against A B W YDoes not proctect against A B W Y
Active IngredientsActive Ingredients
Each .5 ml dose contains 10ug of Neisseria Each .5 ml dose contains 10ug of Neisseria meningitidis Serogroup C oligosaccharide meningitidis Serogroup C oligosaccharide conjugated to 15ug Diphtheriae carrier protein.conjugated to 15ug Diphtheriae carrier protein.
Aluminium phosphateAluminium phosphate
Sodium chlorideSodium chloride
H2OH2O
PresentationPresentation
Prefilled syringe – without a needlePrefilled syringe – without a needle
.5 ml.5 ml
White suspensionWhite suspension
IndicationsIndications
For active immunisation from 6 weeks of For active immunisation from 6 weeks of age to prevent Neisseria meningitidis age to prevent Neisseria meningitidis serogroup Cserogroup C
Not recommended in any elderly Not recommended in any elderly populationspopulations
ContradicationsContradications
Hypersensitivity of any components of the Hypersensitivity of any components of the vaccine vaccine
Any significant neurological s&s or allergic or Any significant neurological s&s or allergic or anaphylactic reaction to prior dose of Meningitecanaphylactic reaction to prior dose of Meningitec
Severe febrile illnessSevere febrile illness
Does not contain eggs or nutsDoes not contain eggs or nuts
PrecautionsPrecautions
Coagulation disorders – Coagulation disorders – only because of the IM only because of the IM injectioninjection
Impaired immune responsive patients –Impaired immune responsive patients – may may have a reduce antibody response to active immunisationhave a reduce antibody response to active immunisation
Not recommended for pregnant or Not recommended for pregnant or
lactating motherslactating mothers
InteractionsInteractions
Can be administered at the same time as Can be administered at the same time as -Oral Polio, Hep B, Hib, DTaP and DT whole cell -Oral Polio, Hep B, Hib, DTaP and DT whole cell
Pertussis, PCV7 and MMRPertussis, PCV7 and MMR
Lower levels of Meningococcal C antibodies Lower levels of Meningococcal C antibodies have been reported with co-administration of have been reported with co-administration of Meningitec and aPMeningitec and aP
Spacing either simultaneously or at any time Spacing either simultaneously or at any time before or afterbefore or after
StorageStorage
Keep in original packagingKeep in original packaging
Refrigerate between 2 and 8 degrees CelsiusRefrigerate between 2 and 8 degrees Celsius
If exposed to temps above 8 degrees Celsius for If exposed to temps above 8 degrees Celsius for 48 hrs accumulatively – must be destroyed.48 hrs accumulatively – must be destroyed.
DO NOT freezeDO NOT freeze
AdministrationAdministration
Shake well before useShake well before use
IM injection onlyIM injection only
Anterolateral thigh in infants and deltoid in Anterolateral thigh in infants and deltoid in older children, adolescents and adultsolder children, adolescents and adults
NOT the gluteal areaNOT the gluteal area
Common (Mild) Adverse ReactionsCommon (Mild) Adverse Reactions
Local reactionLocal reaction Headache, dizziness and light-headednessHeadache, dizziness and light-headedness Aching musclesAching muscles Sleepiness or unsettled sleepSleepiness or unsettled sleep Feeling unwellFeeling unwell Unusual high- pitched cryUnusual high- pitched cry Reduced eating and drinkingReduced eating and drinking D’s and V’sD’s and V’s Stomach cramps or painStomach cramps or pain DyspepsiaDyspepsia FeverFever
Very Rare Adverse EventsVery Rare Adverse Events
Swollen glands in neck, armpits or groin Swollen glands in neck, armpits or groin HHE – hyptonic, hyporesponsive episodeHHE – hyptonic, hyporesponsive episode Pins and needlesPins and needles Petechiae or purpura Petechiae or purpura Loss of muscle toneLoss of muscle tone Decreased sensitivity to touch.Decreased sensitivity to touch.
OrderingOrdering
FAX TO:
Whangarei 09-438-9681
Northland District Health Board (NDHB) Meningitec Vaccine Fax Order Form
Account Name:Account No:
Delivery Address:
Date Required:
Contact Name: Contact Phone:
Special Delivery Instructions:
Vaccine DescriptionProprietary name
(manufacturer) of currently supplied vaccine
No of doses per pfs
Minimum quantity to
orderPRP
CODENo of doses
required
Meningococcal Serogroup C Conjugate Vaccine
.5ml Meningitec (Pfizer) 1 ? 1112045
Please note: If ordering in large volumes, it is recommended that you order the Meningitec vaccine in multiples of 70 doses as this will be the optimum quantity per chilly bin.
Authorised VaccinatorAuthorised Vaccinator
Standing OrdersStanding Orders
PerscriptionPerscription
APPLICATION FOR AUTHORISATION OF CURRENTLY AUTHORISED VACCINATORS
FOR THE MENINGOCOCCAL C VACCINATION PROGRAMME
VACCINATOR’S NAME: ……………………………………………..……………..………WORK POSTAL ADDRESS: ……………………………………………………………….
WORK PHONE NUMBER: …………………………………………………………………
Meningococcal C Immunisation Programme approved by the Medical Officer of Health , Northland District Health Board.
Please provide the following:
A copy of your current non-medical vaccinator authorisation
Please note that vaccinators intending to vaccinate in community-based settings (outreach or offsite) will also need to attach a copy of their Northland DHB Clinical Audit for Community-based Vaccinators.
1.A copy of your current practicing certificate.
Evidence of indemnity insurance
□ I have read the Meningitec® data sheet OR attended a Meningococcal C programme CNE session.Name: …………………………………………………………………………Signed: …………………………………………………………………………Date: ……/……/11
Out of the Programme DosageOut of the Programme Dosage
For infants less than 12 monthsFor infants less than 12 months
- three doses at least 1 month apart- three doses at least 1 month apart
- with a booster dose at or after 12 - with a booster dose at or after 12
monthsmonths
Very pre term babies – Very pre term babies – risk of apnoea – give and risk of apnoea – give and monitormonitor
ReferencesReferences
Consumer and Health Professional data Consumer and Health Professional data sheetssheets
Immunisation Handbook 2011 Immunisation Handbook 2011
Med Division Pfizer AustraliaMed Division Pfizer Australia
MeaslesMeasles
Monday 3 OctMonday 3 Oct
200 confirmed cases of measles in the Auckland 200 confirmed cases of measles in the Auckland region since 30 Mayregion since 30 May
0900 hour 10 confirmed cases reported between 0900 hour 10 confirmed cases reported between Friday 9 am and Monday 9 amFriday 9 am and Monday 9 am
a further 8 suspected cases under investigationa further 8 suspected cases under investigation